For noninfectious diarrhea in adults living with HIV/AIDS who are on ART*
Mytesi® is the ONLY FDA-approved diarrhea treatment that's been studied specifically in adults with HIV/AIDS1
Important Safety Information: MYTESI® is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). MYTESI® is not indicated for the treatment of infectious diarrhea. Read More...
Jaguar’s name is now Jaguar Health!
On Monday, July 31, the merger of Jaguar Animal Health and Napo Pharmaceuticals became effective. Napo focuses on the development and commercialization of proprietary gastrointestinal pharmaceuticals for the global human marketplace from sustainably derived plants used traditionally in rainforest areas. As a result of the merger, Jaguar’s name is now Jaguar Health, Inc., and Napo is a wholly-owned subsidiary of Jaguar, focused on the continuing commercialization of its Mytesi® (crofelemer) product, which is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Serving a Broad Range of Species
Our animal health products will serve companion animals, horses and livestock with prescription and non-prescription products globally.
Access to Powerful, Natural Compounds
Jaguar and Napo maintain a proprietary library of more than 2,300 medicinal plants.
Committed to Human and Animal Health
We are focused on the development & commercialization of human and animal health solutions that are naturally derived & sustainably harvested.
We focus on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
We are committed to identifying human and animal health market opportunities where we can develop targeted products that leverage our broad intellectual property portfolio, deep pipeline and extensive botanical library.